- Home
- PTLO vs KURA Comparison
PTLO vs KURA Comparison
Compare PTLO & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- KURA
- Stock Information
- Founded
- PTLO 1963
- KURA 2014
- Country
- PTLO United States
- KURA United States
- Employees
- PTLO N/A
- KURA N/A
- Industry
- PTLO Restaurants
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTLO Consumer Discretionary
- KURA Health Care
- Exchange
- PTLO Nasdaq
- KURA Nasdaq
- Market Cap
- PTLO 821.9M
- KURA 793.2M
- IPO Year
- PTLO 2021
- KURA N/A
- Fundamental
- Price
- PTLO $11.74
- KURA $7.26
- Analyst Decision
- PTLO Buy
- KURA Strong Buy
- Analyst Count
- PTLO 7
- KURA 11
- Target Price
- PTLO $13.57
- KURA $27.89
- AVG Volume (30 Days)
- PTLO 1.9M
- KURA 1.7M
- Earning Date
- PTLO 02-25-2025
- KURA 02-25-2025
- Dividend Yield
- PTLO N/A
- KURA N/A
- EPS Growth
- PTLO 56.82
- KURA N/A
- EPS
- PTLO 0.42
- KURA N/A
- Revenue
- PTLO $713,803,000.00
- KURA N/A
- Revenue This Year
- PTLO $6.53
- KURA N/A
- Revenue Next Year
- PTLO $11.42
- KURA $233.30
- P/E Ratio
- PTLO $28.18
- KURA N/A
- Revenue Growth
- PTLO 11.02
- KURA N/A
- 52 Week Low
- PTLO $8.38
- KURA $6.98
- 52 Week High
- PTLO $16.17
- KURA $24.17
- Technical
- Relative Strength Index (RSI)
- PTLO 66.31
- KURA 19.21
- Support Level
- PTLO $9.06
- KURA $7.02
- Resistance Level
- PTLO $12.19
- KURA $7.66
- Average True Range (ATR)
- PTLO 0.59
- KURA 0.34
- MACD
- PTLO 0.38
- KURA 0.07
- Stochastic Oscillator
- PTLO 87.11
- KURA 13.76
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.